- Home
- NLSP vs SOPH Comparison
NLSP vs SOPH Comparison
Compare NLSP & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- SOPH
- Stock Information
- Founded
- NLSP 2015
- SOPH 2011
- Country
- NLSP Switzerland
- SOPH Switzerland
- Employees
- NLSP N/A
- SOPH N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NLSP Health Care
- SOPH Health Care
- Exchange
- NLSP Nasdaq
- SOPH Nasdaq
- Market Cap
- NLSP 243.8M
- SOPH 247.0M
- IPO Year
- NLSP 2021
- SOPH 2021
- Fundamental
- Price
- NLSP $4.90
- SOPH $3.50
- Analyst Decision
- NLSP
- SOPH Strong Buy
- Analyst Count
- NLSP 0
- SOPH 3
- Target Price
- NLSP N/A
- SOPH $7.00
- AVG Volume (30 Days)
- NLSP 26.6K
- SOPH 37.0K
- Earning Date
- NLSP 10-11-2024
- SOPH 11-05-2024
- Dividend Yield
- NLSP N/A
- SOPH N/A
- EPS Growth
- NLSP N/A
- SOPH N/A
- EPS
- NLSP N/A
- SOPH N/A
- Revenue
- NLSP N/A
- SOPH $64,938,000.00
- Revenue This Year
- NLSP N/A
- SOPH $7.70
- Revenue Next Year
- NLSP N/A
- SOPH $20.61
- P/E Ratio
- NLSP N/A
- SOPH N/A
- Revenue Growth
- NLSP N/A
- SOPH 20.14
- 52 Week Low
- NLSP $4.08
- SOPH $2.49
- 52 Week High
- NLSP $40.60
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- NLSP 37.46
- SOPH 43.65
- Support Level
- NLSP $4.72
- SOPH $3.03
- Resistance Level
- NLSP $5.50
- SOPH $4.10
- Average True Range (ATR)
- NLSP 0.65
- SOPH 0.28
- MACD
- NLSP 0.02
- SOPH -0.06
- Stochastic Oscillator
- NLSP 28.47
- SOPH 34.81
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.